Bittker Seth Scott
Ronin Institute, Montclair, NJ, USA.
Clin Exp Gastroenterol. 2020 Jan 8;13:1-15. doi: 10.2147/CEG.S222353. eCollection 2020.
The prevalence of celiac disease (CD) has increased significantly in some developed countries in recent decades. Potential risk factors that have been considered in the literature do not appear to provide a convincing explanation for this increase. This has led some researchers to hypothesize that there is a "missing environmental factor" that increases the risk of CD. Based on evidence from the literature, the author proposes that elevation in plasma levels of 1,25-dihydroxyvitamin D [1,25(OH)D] is a missing risk factor for CD, and relatedly that significant oral vitamin D exposure is a "missing environmental factor" for CD. First, elevated plasma levels of 1,25(OH)D are common in CD, especially in the newly diagnosed. Second, nine distinct conditions that increase plasma levels of 1,25(OH)D are either associated with CD or have indications of such an association in the literature. Third, a retrospective study shows that sustained oral vitamin D supplementation in infancy is associated with increased CD risk, and other studies on comorbid conditions support this association. Fourth, large doses of oral vitamin D upregulate many of the same cytokines, chemokines, and toll-like receptors that are upregulated in CD. Fifth, epidemiological evidence, such as the timing of the inception of a CD "epidemic" in Sweden, the increased prevalence of CD in Finland and the United States in recent decades, the unusually low prevalence of CD in Germany, and the differential in prevalence between Finnish Karelians and Russian Karelians, may all be explained by oral vitamin D exposure increasing CD risk. The same is true of some seemingly contradictory results in the literature on the effects of breastfeeding on CD risk. If future research validates this hypothesis, adjustments to oral vitamin D consumption among those who have genetic susceptibility may decrease the risk of CD in these individuals.
近几十年来,乳糜泻(CD)在一些发达国家的患病率显著上升。文献中所考虑的潜在风险因素似乎并不能对此增长提供令人信服的解释。这使得一些研究人员推测存在一种“缺失的环境因素”会增加患CD的风险。基于文献证据,作者提出血浆1,25 - 二羟维生素D [1,25(OH)D]水平升高是CD的一个缺失风险因素,与之相关的是,大量口服维生素D暴露是CD的“缺失环境因素”。首先,血浆1,25(OH)D水平升高在CD患者中很常见,尤其是新诊断的患者。其次,九种不同的可使血浆1,25(OH)D水平升高的情况要么与CD相关,要么在文献中有相关关联的迹象。第三,一项回顾性研究表明婴儿期持续口服维生素D补充剂与CD风险增加有关,其他关于合并症的研究也支持这种关联。第四,大剂量口服维生素D会上调许多与CD中上调的相同的细胞因子、趋化因子和Toll样受体。第五,流行病学证据,如瑞典CD“流行”开始的时间、芬兰和美国近几十年来CD患病率的增加、德国CD异常低的患病率以及芬兰卡累利阿人和俄罗斯卡累利阿人之间患病率的差异,都可以通过口服维生素D暴露增加CD风险来解释。文献中关于母乳喂养对CD风险影响的一些看似矛盾的结果也是如此。如果未来的研究验证了这一假设,对有遗传易感性的人群调整口服维生素D的摄入量可能会降低这些个体患CD的风险。